Neuronata-R retains conditional approval in South Korea
South Korea’s Ministry of Food and Drug Safety (MFDS) updates the stem cell therapy’s approval in May 2026 — as the developer works to resume supply and build a U.S. research baseSEOUL, South Korea, July 19, 2026 /PRNewswire/…









